Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,008,369
+$3,260,227 QoQ
Shares Held
9,178
+9.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#1,210
of 4,622 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Icon Wealth Advisors, LLC holds $36,879,063 across 9 Drug Manufacturers - General names. LLY ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,178 | $11,008,369 | |
| 2 | ABBV |
AbbVie Inc.
|
43,276 | $10,889,972 | |
| 3 | JNJ |
Johnson & Johnson
|
28,114 | $7,140,112 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,305 | $2,480,692 | |
| 5 | PFE |
Pfizer Inc
|
88,537 | $2,131,970 | |
| 6 | AZN |
Astrazeneca PLC
|
6,845 | $1,297,948 | |
| 7 | AMGN |
Amgen Inc
|
2,136 | $773,488 | |
| 8 | NVO |
Novo Nordisk A S
|
15,484 | $742,302 |
All Filings in LLY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,008,369 | 9,178 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $7,748,142 | 8,424 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,432,406 | 14,360 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,111,569 | 14,563 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,017,097 | 14,133 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,729,573 | 14,202 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,292,564 | 12,037 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,505,909 | 9,601 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,806,631 | 9,727 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,196,130 | 9,250 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,378,019 | 9,226 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $5,220,536 | 14,270 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,602,240 | 14,233 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||